Similar biologics in India: A story of access or potential for compromise?

Biosimilars or similar biotherapeutic products are the biological products approved by regulatory agencies based on the demonstration of similarity in quality, safety and efficacy with reference biologics (or original biologics). Though biosimilars could be considered as interchangeable therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Jois, Ramesh, Mukherjee, Sukumar, Rajeswari, S., Rath, P.D., Goyal, Vishal, Gupta, Disha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157901/
https://www.ncbi.nlm.nih.gov/pubmed/33707387
http://dx.doi.org/10.4103/ijmr.IJMR_43_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157901/
https://www.ncbi.nlm.nih.gov/pubmed/33707387
http://dx.doi.org/10.4103/ijmr.IJMR_43_18

Ejemplares similares